Campbell David Alan
Director, President and CEO · 1 filing · Latest: Jul 8, 2026
Janux Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
JANX | Campbell David Alan | Director, President and CEO | Jul 8, 2026 | Option Exercise | $4.21 | 7,000 | $29.5K | 388,582 | |
JANX | Campbell David Alan | — | Jan 7, 2025 | Proposed Sale | $60.00 | 5,000 | $300.0K | — | |
JANX | Campbell David Alan | — | Dec 26, 2024 | Proposed Sale | $56.19 | 25,000 | $1.4M | — | |
JANX | Campbell David Alan | — | Sep 27, 2024 | Proposed Sale | $48.33 | 90,000 | $4.3M | — |